Olfaction Disorders: Clinical Trials

2 trials for Olfaction Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2
Phase 21Terminated 1

Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
Smell Retraining, Budesonide - Dysosmia, Anosmia
Phase 1 / Phase 2TerminatedAmanda Stapleton202021-09-302024-06-13
Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell
Placebo spray, Diltiazem - Food Intake
Phase 1TerminatedPennington Biomedical Research Center122009-10-012015-12-18

Narrower conditions

Anosmia (2)  ·  COVID-19 (1)

Broader conditions

Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sensation Disorders (2)  ·  Signs and Symptoms (2)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)

Interventions

Budesonide (1)  ·  Diltiazem (1)  ·  Olfactory Training (1)

Sponsors

Amanda Stapleton (1)  ·  Pennington Biomedical Research Center (1)

Countries

United States (2)

Top investigators

Amanda L Stapleton, MD (1)  ·  Frank L. Greenway, MD (1)